Market Access

PM Society Market Access Interest Group

Market access is central to the success of the healthcare industry and to patient outcomes. The term means something different to each of these stakeholder groups and equally to individual companies, health providers or patient organisations, according to their size and needs.

Principally market access involves preparing a positive environment which supports uptake of your product and demonstrating the ‘value’ of your product to the range of customers who influence uptake. Strategically, market access is about packaging data in the right way, for the right customer at the right time.

The PM Society Market Access Interest Group will address the growing need for multiple stakeholders to understand their role in ‘market access’. Discussions are likely to be as diverse as the pharma/life sciences industries-patient dialogue, evidence requirements in the context of payer needs, the role of NHS liaison and the move from risk-sharing to value-based pricing. The Market Access group will also look to define, for the first time, the pharma and life sciences industries’ priority concerns relating to market access and, in time, to find practical solutions for overcoming barriers and establishing best practice.

The PM Society Market Access interest group is open to anyone interested in understanding more about market access and will be focused on:

  • Learning and education
  • Celebrating best practice
  • Providing an opportunity to exchange ideas and network

We meet regularly to discuss common issues and work on the principles of equity of access and equity to innovation. We meet regularly and anyone who has an interest would be welcome to join us.

Membership of the group is open to anyone with an interest in market access in its broadest sense, but the Society is particularly keen to hear from industry representatives. Please email Helen or call 01403 264898 if you are interested in finding out more or to join the group.

Latest Market Access Articles